Necessity of prophylactic drainage tube in retroperitoneal laparoscopic nephroureterectomy with open distal ureterectomy: A matched-pair analysis.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
07 2023
Historique:
received: 07 10 2022
accepted: 03 03 2023
medline: 31 7 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: ppublish

Résumé

To assess the necessity of prophylactic drain placement in retroperitoneal laparoscopic nephroureterectomy with open distal ureterectomy for upper tract urothelial cancer. Between July 2011 and March 2021, 200 patients with localized clinical Tis-T3 upper urinary tract urothelial carcinoma underwent laparoscopic nephroureterectomy with open distal ureterectomy. After removing the specimen, drainage tubes were placed on the renal beds and/or in the retrovesical spaces. Drain tubes were omitted for most patients after 2017. We compared the postoperative outcomes between the patients with drain placement (D+ group) and without drain placement (D- group) using propensity score matching. A total of 164 patients (90 in the D+ group and 74 in the D- group) were enrolled, and matched pairs of 108 patients were analyzed. There was no significant difference in the incidence of complications according to Clavien-Dindo grade in the two groups after the propensity score matching. There was no significant difference in the incidence of postoperative lymphocele (n = 5 vs. 9, p = 0.395) and symptomatic lymphocele (n = 1 vs. 1, p = 1) between the two groups. The length of hospital stay was significantly shorter in the D- group (11 vs. 8 days, p < 0.0001). We found that omitting the drainage tube after laparoscopic radical nephroureterectomy did not increase postoperative complications or lymphocele and shortened the post-hospital stay.

Identifiants

pubmed: 36951440
doi: 10.1111/iju.15182
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-584

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Japanese Urological Association.

Références

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
Kenigsberg AP, Meng X, Ghandour R, Margulis V. Oncologic outcomes of radical nephroureterectomy (RNU). Transl Androl Urol. 2020;9:1841-52.
Roupret M, Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79:62-79.
Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Meretyk S, Darcy MD, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146:278-82.
Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, et al. Oncological outcomes of laparoscopic Nephroureterectomy versus open radical Nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review. Eur Urol Focus. 2019;5:205-23.
Nanigian DK, Smith W, Ellison LM. Robot-assisted laparoscopic nephroureterectomy. J Endourol. 2006;20:463-5. discussion 5-6, 466.
Mullen E, Ahmed K, Challacombe B. Systematic review of open versus laparoscopic versus robot-assisted nephroureterectomy. Rev Urol. 2017;19:32-43.
Veccia A, Carbonara U, Derweesh I, Mehrazin R, Porter J, Abdollah F, et al. Single-stage xi® robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes. Minerva Urol Nephrol. 2022;74:233-41.
Veccia A, Antonelli A, Francavilla S, Simeone C, Guruli G, Zargar H, et al. Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases. World J Urol. 2020;38:845-52.
Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, Wein A. Campbell-Walsh-Wein Urology. 12th ed. Amsterdam: Elsevier B.V. publish Campbell-Walsh-Wein Urology. 2020. p. 2200.
Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, et al. Potential benefit of lymph node dissection during radical Nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European Association of Urology guidelines panel on non-muscle-invasive bladder cancer. Eur Urol Focus. 2019;5:224-41.
Kowalewski KF, Hendrie JD, Nickel F, von Hardenberg J, Nuhn P, Honeck P, et al. Prophylactic abdominal or retroperitoneal drain placement in major uro-oncological surgery: a systematic review and meta-analysis of comparative studies on radical prostatectomy, cystectomy and partial nephrectomy. World J Urol. 2020;38:1905-17.
Ni S, Tao W, Chen Q, Liu L, Jiang H, Hu H, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2012;61:1142-53.
Levy A, Canes D. Perioperative complications and adverse sequelae of radical nephroureterectomy. Transl Androl Urol. 2020;9:1853-9.
Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, et al. Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. Urol Oncol. 2015;33(426):e1-12.
Veccia A, Carbonara U, Djaladat H, Mehazin R, Eun DD, Reese AC, et al. Robotic vs laparoscopic nephroureterectomy for upper tract urothelial carcinoma: a multicenter propensity-score matched pair “tetrafecta” analysis (ROBUUST collaborative group). J Endourol. 2022;36:752-9.
Hakimi K, Carbonara U, Djaladat H, Mehrazin R, Eun D, Reese A, et al. Outcomes of lymph node dissection in nephroureterectomy in the treatment of upper tract urothelial carcinoma: analysis of the ROBUUST registry. J Urol. 2022;208:268-76.

Auteurs

Hiroki Hagimoto (H)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Takanari Kambe (T)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Yuta Mine (Y)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Hidetoshi Kokubun (H)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Yuto Hattori (Y)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Yohei Abe (Y)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Masashi Kubota (M)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Naofumi Tsutsumi (N)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Toshinari Yamasaki (T)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Mutsushi Kawakita (M)

Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH